![]() |
|
|
CJ Carter, KG Lloyd, B Zivkovic and B Scatton
Synthelabo Recherche, Biology Department, Bagneux, France.
Ifenprodil and SL 82.0715 are noncompetitive N-methyl-D-aspartate (NMDA) antagonists whose inhibitory actions are not explained by antagonistic effects at any of the three commonly recognized sites within the NMDA receptor complex (recognition, channel and modulatory glycine sites). We presently show that ifenprodil and SL 82.0715 antagonize the effects of NMDA via a selective action at the recently described polyamine modulatory site. Spermine and spermidine (0.5-100 microM) increase the binding of [3H]1-[1-(2-thienyl)cyclohexyl] piperidine to washed rat forebrain membranes in the presence of glutamate (10 microM). This effect is antagonized by ifenprodil and SL 82.0715 (0.1-10 microM) at concentrations which do not displace [3H]1- (2-thienyl)cyclohexyl] piperidine in the absence of added polyamine. Spermine and spermidine (up to 100 microM) do not significantly alter the binding of [3H]glycine but increase the binding of the NMDA recognition site ligand [3H](+/-)-3-(2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid. Ifenprodil and SL 82.0715 (0.1-10 microM) antagonize this effect; ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5- 10-imine maleate) or 7-chlorokynurenate (100 microM) are ineffective. In immature rat cerebellar slices, spermine and spermidine (10-1000 microM) potentiate the maximal effects of NMDA (80-160 microM) on cyclic GMP production. Spermine (100-1000 microM) reverses the antagonistic effects of ifenprodil (0.15-50 microM) but not of ((+)-5- methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-10-imine acid or kynurenate on the NMDA receptor-mediated increase in cyclic GMP levels. Ifenprodil (0.01-1 microM) potently but only partially antagonizes the depolarizing effects of NMDA (10 microM) on the immature rat spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
P. Malherbe, V. Mutel, C. Broger, F. Perin-Dureau, J. A. Kemp, J. Neyton, P. Paoletti, and J. N. C. Kew Identification of Critical Residues in the Amino Terminal Domain of the Human NR2B Subunit Involved in the RO 25-6981 Binding Pocket J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 897 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Masuko, T. Kuno, K. Kashiwagi, T. Kusama, K. Williams, and K. Igarashi Stimulatory and Inhibitory Properties of Aminoglycoside Antibiotics at N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1026 - 1033. [Abstract] [Full Text] |
||||
![]() |
M. L. Berger and P. Rebernik Zinc and Ifenprodil Allosterically Inhibit Two Separate Polyamine-Sensitive Sites at N-Methyl-D-Aspartate Receptor Complex J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1584 - 1591. [Abstract] [Full Text] |
||||
![]() |
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969. [Abstract] [Full Text] |
||||
![]() |
K. A. Keefe and A. C. Adams Differential Effects of N-Methyl-D-Aspartate Receptor Blockade on Eticlopride-Induced Immediate Early Gene Expression in the Medial and Lateral Striatum J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1076 - 1083. [Abstract] [Full Text] |
||||
![]() |
L. L. Coughenour and J. J. Cordon Characterization of Haloperidol and Trifluperidol as Subtype-Selective N-Methyl-D-Aspartate (NMDA) Receptor Antagonists Using [3H]TCP and [3H]Ifenprodil Binding in Rat Brain Membranes J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 584 - 592. [Abstract] [Full Text] |
||||
![]() |
M. J. Gallagher, H. Huang, D. B. Pritchett, and D. R. Lynch Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor J. Biol. Chem., April 19, 1996; 271(16): 9603 - 9611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Ginsberg REVIEW {blacksquare} : Neuroprotection in Brain Ischemia: An Update (Part I Neuroscientist, March 1, 1995; 1(2): 95 - 103. [Abstract] [PDF] |
||||